
### [MONDO:0000612](http://purl.obolibrary.org/obo/MONDO_0000612)
**Label:** lymphatic system cancer

**Subclasses:** [MONDO:0016973](http://purl.obolibrary.org/obo/MONDO_0016973) (thymoma type a), [MONDO:0016975](http://purl.obolibrary.org/obo/MONDO_0016975) (thymoma type AB), [MONDO:0006456](http://purl.obolibrary.org/obo/MONDO_0006456) (thymoma (disease)), [MONDO:0016974](http://purl.obolibrary.org/obo/MONDO_0016974) (thymoma type b), [MONDO:0006451](http://purl.obolibrary.org/obo/MONDO_0006451) (thymic carcinoma), [MONDO:0018153](http://purl.obolibrary.org/obo/MONDO_0018153) (Erdheim-Chester disease), [MONDO:0019462](http://purl.obolibrary.org/obo/MONDO_0019462) (splenic marginal zone lymphoma), [MONDO:0009975](http://purl.obolibrary.org/obo/MONDO_0009975) (reticulum cell sarcoma), [MONDO:0010017](http://purl.obolibrary.org/obo/MONDO_0010017) (sea-blue histiocyte syndrome), [MONDO:0010127](http://purl.obolibrary.org/obo/MONDO_0010127) (thymoma, familial), 

**Corr. equiv. classes:** [Orphanet:263317](http://www.orpha.net/ORDO/Orphanet_263317), [Orphanet:263324](http://www.orpha.net/ORDO/Orphanet_263324), [Orphanet:86854](http://www.orpha.net/ORDO/Orphanet_86854), [Orphanet:158029](http://www.orpha.net/ORDO/Orphanet_158029), [Orphanet:35687](http://www.orpha.net/ORDO/Orphanet_35687), [Orphanet:99867](http://www.orpha.net/ORDO/Orphanet_99867), [Orphanet:263310](http://www.orpha.net/ORDO/Orphanet_263310), [Orphanet:99868](http://www.orpha.net/ORDO/Orphanet_99868), [Orphanet:86900](http://www.orpha.net/ORDO/Orphanet_86900), [OMIM:274230](http://purl.obolibrary.org/obo/OMIM_274230), [OMIM:269600](http://purl.obolibrary.org/obo/OMIM_269600), [OMIM:267730](http://purl.obolibrary.org/obo/OMIM_267730), 

**Class expressions from DL-Learner:**

- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) and [HP:0045027](http://purl.obolibrary.org/obo/HP_0045027) (Abnormality of the thoracic cavity) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 51.23%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) and [HP:0045026](http://purl.obolibrary.org/obo/HP_0045026) (Abnormality of the mediastinum) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 51.23%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0002733](http://purl.obolibrary.org/obo/HP_0002733) (Abnormality of the lymph nodes) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) and [HP:0045027](http://purl.obolibrary.org/obo/HP_0045027) (Abnormality of the thoracic cavity) 51.23%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0002733](http://purl.obolibrary.org/obo/HP_0002733) (Abnormality of the lymph nodes) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) and [HP:0045026](http://purl.obolibrary.org/obo/HP_0045026) (Abnormality of the mediastinum) 51.23%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) and [HP:0045027](http://purl.obolibrary.org/obo/HP_0045027) (Abnormality of the thoracic cavity) 51.23%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) and [HP:0045026](http://purl.obolibrary.org/obo/HP_0045026) (Abnormality of the mediastinum) 51.23%
- [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) and [HP:0045027](http://purl.obolibrary.org/obo/HP_0045027) (Abnormality of the thoracic cavity) 51.23%
- [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) and [HP:0045026](http://purl.obolibrary.org/obo/HP_0045026) (Abnormality of the mediastinum) 51.23%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) and [HP:0045027](http://purl.obolibrary.org/obo/HP_0045027) (Abnormality of the thoracic cavity) 51.23%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) and [HP:0045026](http://purl.obolibrary.org/obo/HP_0045026) (Abnormality of the mediastinum) 51.23%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) and [HP:0045027](http://purl.obolibrary.org/obo/HP_0045027) (Abnormality of the thoracic cavity) 47.86%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) and [HP:0045026](http://purl.obolibrary.org/obo/HP_0045026) (Abnormality of the mediastinum) 47.86%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) and [HP:0045027](http://purl.obolibrary.org/obo/HP_0045027) (Abnormality of the thoracic cavity) 47.86%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) and [HP:0045026](http://purl.obolibrary.org/obo/HP_0045026) (Abnormality of the mediastinum) 47.86%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0030669](http://purl.obolibrary.org/obo/HP_0030669) (Abnormal morphology of the ocular adnexa) and [HP:0045027](http://purl.obolibrary.org/obo/HP_0045027) (Abnormality of the thoracic cavity) 47.86%


